The Hierarchy of Proinflammatory Cytokines in Ocular Inflammation
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
PURPOSE: The concept of tissue-dependent cytokine hierarchy has been demonstrated in a number of diseases, but it has not been investigated in ophthalmic diseases. Here, we evaluated the functional hierarchy of interleukin-1β (IL-1β), IL-6, IL-17A, and tumor necrosis factor (TNF) in the induction of ocular inflammation. MATERIALS AND METHODS: We delivered adeno-associated virus (AAV) vectors expressing IL-1β, IL-6, IL-17A, or TNF intravitreally in naïve C57/BL6 mice and compared and contrasted the inflammatory effects in the eye 5 weeks after AAV-mediated gene transfer. We also used an in vitro human system to test the effect of cytokines on barrier function. RESULTS: We found that IL-1β had the highest ability to initiate ocular inflammation. The continuous overexpression of IL-1β resulted in a significant upregulation of additional proinflammatory mediators in the eye. Using scanning laser ophthalmoscope and optical coherence tomography imaging techniques, we showed that a low dose of AAVIL-1β was sufficient and was as pathogenic as a high dose of TNF in inducing vascular leakage, retinal degeneration, and cellular infiltration. Furthermore, only a marginal increase in IL-1β was enough to cause cellular infiltration, thus confirming the highly pathogenic nature of IL-1β in the eye. Contrary to our expectation, IL-6 or IL-17A had minimal or no effect in the eye. To examine the clinical relevance of our findings, we used an impedance assay to show that IL-1β alone or TNF alone was able to cause primary human retinal endothelial cell barrier dysfunction in vitro. Again, IL-6 alone or IL-17A alone had no effect on barrier function; however, in the presence of IL-1β or TNF, IL-17A but not IL-6 may provide additive proinflammatory effects. CONCLUSIONS: Our studies demonstrate the existence of a functional hierarchy of proinflammatory cytokines in the eye, and we show that IL-1β is the most pathogenic when it is continuously expressed in the eye.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, retinal inflammation can induce local expression of pro-inflammatory cytokines and chemokines and can upregulate adhesion molecules on the basal RPE membrane, which leads to the recruitment of leukocytes and breakdown of the blood-retinal barrier.10,11”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [11]
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
Fanning, A. S., Jameson, B. J., Jesaitis, L. A., & Anderson, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29745 · Cited by 1,432
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811 · cited 1×
“IL-6 is a multifunctional, pleiotropic cytokine involved in hematopoiesis and inflammation.(15) IL-6 is secreted by T cells and macrophages to stimulate proinflammatory immune responses against infectious agents.”
BackgroundTherapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683 · cited 1×
“Inhibition of interleukin-6 (IL-6) signaling is effective in treating rheumatoid arthritis, yet this strategy has shown limited efficacy or even failed in other chronic diseases.(3,4) IL-1β inhibitors were developed for the treatment of rheumatoid arthritis, but they have so far shown no convincing benefits.”
BackgroundInternational Journal of Cancer
(2006) · International Journal of Cancer · doi:10.1002/(issn)1097-0215 · Cited by 665
Ito, H., Takazoe, M., Fukuda, Y., Hibi, T., Kusugami, K., Andoh, A., Matsumoto, T., Yamamura, T., Azuma, J., & Nishimoto, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.012 · Cited by 636
IL-1 stimulates IL-6 production in endothelial cells.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E., & Mantovani, A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.549 · Cited by 521
Larsen, C. G., Anderson, A. O., Oppenheim, J. J., & Matsushima, K. (1989) · PubMed Central · Cited by 424
Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A. (2010) · Diabetes · doi:10.2337/db09-1606 · Cited by 403
Interleukin‐6 Gene‐Deficient Mice Show Impaired Defense against Pneumococcal Pneumonia
van der Poll, T., Keogh, C. V., Guirao, X., Buurman, W. A., Kopf, M., & Lowry, S. F. (1997) · The Journal of Infectious Diseases · doi:10.1086/514062 · Cited by 382
Research works printed but not linked: 6
- Shams NB, 1986, Invest Ophthalmol Vis Sci, 27, 1543
- 10.1086/jid.1997.176.issue-2 · doi:10.1086/jid.1997.176.issue-2
- Larsen CG, 1989, Immunol, 68, 31
- Fleisher LN, 1992, Invest Ophthalmol Vis Sci, 33, 2120
- Bamforth SD, 1997, Am J Pathol, 150, 329
- Hoekzema R, 1991, Invest Ophthalmol Vis Sci, 32, 88
Cited by
Wooff, Y., Man, S. M., Aggio-Bruce, R., Natoli, R., & Fernando, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01618 · Cited by 246
“This led to an upregulation of inflammatory factors CXCL1, CCL2, MMP9, VCAM-1, VEGFA, IL-6, and IL-17A, reduced photoreceptor thickness, increased cellular infiltrates, and damage to the overall structural integrity of the posterior eye (253).”
BackgroundFerreira, L. B., Williams, K. A., Best, G., Haydinger, C. D., & Smith, J. R. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1479 · Cited by 55
Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy
Tomkins‐Netzer, O., Niederer, R. L., Greenwood, J., Fabian, I. D., Serlin, Y., Friedman, A., & Lightman, S. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101245 · Cited by 48
“Using a different approach, da Cunha et al. (Da Cunha et al., 2018), introduced AAV vectors carrying the gene for IL-1 β and reported sustained leakage of the mouse BRB that also correlated with a pronounced cellular infiltrate.”
MethodCharacterizing the cellular immune response to subretinal AAV gene therapy in the murine retina
Chandler, L. C., McClements, M. E., Yusuf, I. H., Martinez-Fernandez de la Camara, C., MacLaren, R. E., & Xue, K. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.011 · Cited by 43
“leads to the recruitment of leukocytes and breakdown of the bloodretinal barrier.(10,11) We and others have shown that in vivo AAV subretinal injections induce the expression of pro-inflammatory cytokines and chemokines, including tumor necrosis factor-a (Tnf-a), interleukin-1b (Il-1b), and C-X-C motif chemokine ligan…”
BackgroundSantos, F. M., Ciordia, S., Mesquita, J., Sousa, J. P. C., Paradela, A., Tomaz, C. T., & Passarinha, L. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04670-y · Cited by 42
The Immunomodulatory Potential of Mesenchymal Stem Cells in a Retinal Inflammatory Environment
Heřmánková, B., Kössl, J., Boháčová, P., Javorková, E., Hájková, M., Krulová, M., Zajícová, A., & Holáň, V. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09908-0 · Cited by 32
Tien, P., Lin, C.-H., Chen, C.-S., Chang, C., Ku, H., Gan, D., Tsai, Y., Chen, J. J.-Y., Lin, H., & Wan, L. (2021) · Mediators of Inflammation · doi:10.1155/2021/6660640 · Cited by 26
“Overexpression of TNF-α and IL-1β in the eye initiates a proinflammatory cascade that leads to ocular inflammation [14].”
Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells
Ferreira, L. B., Ashander, L. M., Ma, Y., Appukuttan, B., Williams, K. A., Best, G., & Smith, J. R. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156407 · Cited by 24
AAV-Mediated Expression of Human VEGF, TNF-α, and IL-6 Induces Retinal Pathology in Mice
Weigelt, C. M., Fuchs, H., Schönberger, T., Stierstorfer, B., Strobel, B., Lamla, T., Ciossek, T., Bakker, R. A., & Redemann, N. H. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.11.15 · Cited by 18
“32 However, we only studied mice 6 weeks after IVT treat-ment with AAV-IL-6, due to the subtle effects of IL-6, it might take longer to see severe inflammation or reactive gliosis.”
InfluentialArora, N., Caldwell, A., Wafa, K., Szczesniak, A.-M., Caldwell, M. D., Al-Banna, N., Sharawy, N., Islam, S., Zhou, J., Holbein, B. E., et al. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189109 · Cited by 18
Weigelt, C. M., Zippel, N., Fuchs, H., Rimpelä, A., Schönberger, T., Stierstorfer, B., Bakker, R. A., & Redemann, N. H. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.5.18 · Cited by 17
Human retinal endothelial cells express functional interleukin-6 receptor
Ferreira, L. B., Ashander, L. M., Appukuttan, B., Ma, Y., Williams, K. A., Best, G., & Smith, J. R. (2023) · Journal of Ophthalmic Inflammation and Infection · doi:10.1186/s12348-023-00341-6 · Cited by 15
“[27] reported that application of IL-6 to human retinal endothelial cells did not alter transcellular electrical resistance using a biosensor method similar to ours, while Valle et al.”
MethodCytokine Expression in Staphylococcal and Streptococcal Endophthalmitis
Soon, M. Y., Allen, P. J., & Dawkins, R. C. H. (2022) · Biomedicine Hub · doi:10.1159/000525330 · Cited by 12
Innate Immune Interference Attenuates Inflammation In Bacillus Endophthalmitis
Mursalin, M. H., Coburn, P. S., Miller, F. C., Livingston, E. T., Astley, R., & Callegan, M. C. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.13.17 · Cited by 12
Lee, H.-Y., Chen, J., Ying, P., Xu, S., Kang, M. C., Zou, J., Liao, X., Shi, W., Ling, Q., Wang, Y., et al. (2023) · Bioscience Reports · doi:10.1042/bsr20230045 · Cited by 11
Peters, M. C. C., de Oliveira, I. F., Machado, M. G. M., Ferreira, D. C., Zanin, M. H. A., & Bou‐Chacra, N. A. (2020) · Materials Today Chemistry · doi:10.1016/j.mtchem.2020.100396 · Cited by 11
Lu, X., Zhai, H., Dong, Y. F., Su, F., Xie, Y., Wang, Y., Wang, L., Li, J., & Xu, P. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/2910849 · Cited by 11
“Both TNF-α and IL-1β are major players in the hierarchy of proinflammatory mediator cascades [17], while nitric oxide (NO) and oxygen free radicals are secondary effectors of cardiac depression in systemic inflammatory response syndromes [11].”
BackgroundCircular Rims2 Deficiency Causes Retinal Degeneration
Sun, L., Ma, Y., Ji, Y., Wu, Z., Wang, Y., Mou, H., & Jin, Z. (2021) · Advanced Biology · doi:10.1002/adbi.202100906 · Cited by 10
Bonilla-Vidal, L., Espina, M., García, M. L., Baldomà, L., Badía, J., Gliszczyńska, A., Souto, E. B., & Sánchez‐López, E. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.125160 · Cited by 8
Mesenchymal stem cell-derived exosomes as new remedy for the treatment of inflammatory eye diseases
Harrell, C. R., Volarevic, A., Pavlović, D., Djonov, V., & Volarević, V. (2022) · Biocell · doi:10.32604/biocell.2022.020175 · Cited by 8
IL-10 and IL-6/IL-10 as predictive biomarkers for treatment response in non-infectious uveitis
Valenzuela, R. A., Vega‐Tapia, F., Nathaly Elizalde, A., Flores, I., Rojas, F. M., Annelise Goecke, S., Cuitiño, L., & Urzúa, C. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584905 · Cited by 6
Natural pigments as multifunctional additives in contact lenses
Muhammed Shebeeb, C., Chandran, S., Jacob, L., Sajini, A. A., & Butt, H. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.113748 · Cited by 5
Ink based graphene integration into commercial contact lenses
Muhammed Shebeeb, C., Chandran, S., Hisham, M., Jacob, L., Shanavas, S., Samad, Y. A., Sajini, A. A., & Butt, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-15904-x · Cited by 5
“P < 0.05 results were considered to be significant 21,23 .”
InfluentialNanotechnological approaches to improve corticosteroids ocular therapy
Formica, M. L., Scerbo, J. M. P., Alfonso, H. G. A., Palmieri, P. T., Ribotta, J., & Palma, S. D. (2024) · Methods · doi:10.1016/j.ymeth.2024.12.008 · Cited by 5
Tomita, M., Tagami, M., Misawa, N., Sakai, A., Haruna, Y., & Honda, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297201 · Cited by 4
Becker, K., Weigelt, C. M., Fuchs, H., Viollet, C., Rust, W., Wyatt, H., Huber, J., Lamla, T., Fernández-Albert, F., Simon, E., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23065-4 · Cited by 4
Trivedi, P., Singh, S., Dowari, S., Jedhe, N., Rana, K., Srivastava, R., & Gajjar, D. U. (2025) · Apmis · doi:10.1111/apm.70120 · Cited by 3
“IL-1β is the most potent cytokine for causing eye inflammation [34].”
Influence of interleukin 17 A and 17 F polymorphisms in keratoconus
Gomes, I. B., Ayo, C. M., Lopes, A. G., Kumano, L. S., de Faria, G. M., de Almeida, G. C., Castiglioni, L., de Mattos, L. C., & Brandão, C. C. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06708-z · Cited by 3
Huang, C., Babu, V. S., Bammidi, S., Arnold, J., Ebeling, M., Widmer, G., Strassburger, P., Lazendic, M., Grüner, S., Koester, J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08491-w · Cited by 2
Kadmiel, M., Díaz-Jiménez, D., Oakley, R. H., Petrillo, M. G., He, B., Xu, X., & Cidlowski, J. A. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.06.005 · Cited by 2
Fahey, E., Celkova, L., Frezza, V., Sullivan, G. P., Byrne, K., Watson, A., Hernandez-Santana, Y., Byrne, K., Dalton, R., Efe-Cicek, H., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116549 · Cited by 2
Aslam, A., Gupta, N., Velpandian, T., & Sen, S. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225384 · Cited by 2
Mirzapour, P., McCanna, D. J., & Jones, L. (2021) · Contact Lens and Anterior Eye · doi:10.1016/j.clae.2021.02.016 · Cited by 2
Bhandari, R., Singh, R. D., Rao, J., Tripathi, S., Gupta, P., & Gupta, S. K. (2025) · Journal of Prosthetic Dentistry · doi:10.1016/j.prosdent.2024.12.009 · Cited by 1
Interaction of Tear Inflammatory Markers with Contact Lens Materials
Mirzapour, P. (2020) · UWSpace (University of Waterloo)
In Vitro Release of Inflammatory Cytokines from Contact Lens Materials
Nagaarudkumaran, N. (2020) · UWSpace (University of Waterloo)
IL17A G197A and IL17F T7488C genotypes of IL-17 gene as biomarkers in keratoconusPreprint
Gomes, I. B., Ayo, C. M., Lopes, A. G., Kumano, L. S., de Faria, G. M., de Almeida, G. C., Castiglioni, L., de Mattos, L. C., & Brandão, C. C. (2021) · Research Square · doi:10.21203/rs.3.rs-563390/v1
Innate immunity gene expression profiles in conjunctival membrane biopsies from Amazonian buffalo
Paredes, L. J. A., Pereira, W. L. A., SOUSA, R. T. D. R., Bernal, M. K. M., Guimarães, R. C., MESQUITA, E. F., Santos, C. L., Barbosa, E. M., FAVACHO, H. G. S., Huffman, M. A., et al. (2022) · Acta Amazonica · doi:10.1590/1809-4392202100893
“2018; Da Cunha et al .”
AAV-mediated inducible co-expression of IL-10 and IL-1RN for ocular inflammatory diseases
Castro, B. F. M., Steel, J. C., & Layton, C. J. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107591
Hedley, R. (2021) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-mzdeezaby
สารสกัดผลมะเกี๋ยงลดการอักเสบจากการเหนี่ยวนำด้วยอินเตอร์ลิวคิน-1 เบต้าในเซลล์จอประสาทตามนุษย์
Srimard, P., Muangnoi, C., Tuntipopipat, S., Charoenkiatkul, S., & Sukprasansap, M. (2022) · Journal of Nutrition Association of Thailand (Online)
Tomita, M., Tagami, M., Misawa, N., Sakai, A., Haruna, Y., & Honda, S. (2024) · doi:10.1371/journal.pone.0297201.r005
Metadata
- Authors
- Da Cunha, A. P., Zhang, Q., Prentiss, M., Wu, X. Q., Kainz, V., Xu, Y. Y., Vrouvlianis, J., Li, H., Rangaswamy, N., Leehy, B., McGee, T. L., Bell, C. L., Bigelow, C. E., Kansara, V., Medley, Q., Huang, Q., & Wu, H. Y.
- Affiliations
- Department of Ophthalmology, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, USA
- Corresponding author
- Wu, H. Y.
- Venue
- Current Eye Research
- Publisher
- Informa UK Limited
- Published
- 2017-12-04
- Volume
- 43
- Issue
- 4
- Pages
- 553-565
- ISSN
- 0271-3683 (ISSN-L)
- 1460-2202
- OpenAlex
- W2771379188
- Cited by
- 40
- References
- 37
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 3 · 2019: 2 · 2018: 2
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Current Eye Research (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Keywords
- ocular inflammation, inflammatory cytokines, IL-1β, interleukin-6, IL-17A, TNF-α, AAV gene delivery, intravitreal delivery, vascular leakage, retinal degeneration, cell infiltration
- MeSH terms
- Animals, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Female, Gene Expression Regulation, Inflammation, Male, Mice, Inbred C57BL, Endophthalmitis, Retinal Artery, RNA, Cytokines, Tomography, Optical Coherence, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.